Temozolomide plus pegylated interferon alfa-2b as first-line treatment for stage IV melanoma: a multicenter phase II trial of the Dermatologic Cooperative Oncology Group (DeCOG). (Q33378171)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Temozolomide plus pegylated interferon alfa-2b as first-line treatment for stage IV melanoma: a multicenter phase II trial of the Dermatologic Cooperative Oncology Group (DeCOG). |
scientific article |
Statements
1 reference
Temozolomide plus pegylated interferon alfa-2b as first-line treatment for stage IV melanoma: a multicenter phase II trial of the Dermatologic Cooperative Oncology Group (DeCOG). (English)
1 reference
K Spieth
1 reference
R Kaufmann
1 reference
R Dummer
1 reference
C Garbe
1 reference
J C Becker
1 reference
A Hauschild
1 reference
W Tilgen
1 reference
S Ugurel
1 reference
M Beyeler
1 reference
E B Bröcker
1 reference
K C Kaehler
1 reference
C Pföhler
1 reference
J Gille
1 reference
D Schadendorf
1 reference
4 January 2008
1 reference
1 reference
19
1 reference
801-806
1 reference
Identifiers
1 reference
1 reference